Purchase Order 75F40125P00167

Award Date 8/5/25
Potential Completion Date 9/29/26
Potential Value $91K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $210,000 firm-fixed price purchase order contract to Digim Solution LLC, a minority-owned, for-profit, Asian-Pacific American business based in Woburn, Massachusetts. The contract is for advanced product characterization and artificial intelligence analysis services, with a completion date of August 9, 2025. This contract award is part of a larger $5,000,500 indefinite delivery vehicle (IDV) contract between the FDA and Digim Solution LLC,...
The U.S. Food and Drug Administration (FDA) has awarded a firm-fixed-price purchase order to Digim Solution LLC, a minority-owned, for-profit Asian-Pacific American business, for image processing, modeling, and drug release simulation software under the AIDAN project. The $91,390.00 contract has a period of performance ending on September 29, 2025. Digim Solution LLC is a contractor that has received multiple awards from the Department of Health and Human Services, including the FDA and...
This is a $709,554 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to Digim Solution LLC, a minority-owned small business. The contract is for correlative 3D imaging and AI analysis to establish critical performance attributes of polymeric microsphere products in support of performance evaluation. This work was originally solicited through an FDA Broad Agency Announcement that sought research and development proposals to advance regulatory science across...
This is a task order awarded by the Food and Drug Administration (FDA) to Digim Solution LLC, a minority-owned small business, under an indefinite-delivery, indefinite-quantity (IDIQ) contract. The task order is for 3D microscopy, AI-based quantification, and modeling to support non-clinical evaluation and regulatory submissions for complex injectable and insertable drug products. The task order has a firm fixed price of $360,000.00 and a period of performance through March 9, 2026. Digim...
This is a $3,596,546.58 firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Distributed Technology Group LLC (DTG), a Service-Disabled Veteran-Owned Small Business (SDVOSB). The contract is for MicroFocus software licenses and maintenance, and is set aside for total small business participation. DTG is a subsidiary of Red River Technology LLC, a provider of comprehensive IT solutions to federal agencies. The contract was awarded under the NASA Solutions for...
This federal contract award, valued at $496,171, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract is for expanding patient-generated health data training, which supports the FDA's Center for Devices and Radiological Health's (CDRH) need to enhance its capabilities in this area. The contract is structured as a Definitive Firm Fixed Price arrangement and does not have a set-aside...
This contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Digital Infuzion, Inc., a minority-owned, for-profit Subchapter S corporation that provides software and healthcare IT services. The contract, valued at $730,303.96, was awarded under a Broad Agency Announcement (BAA) entitled "Integrating EHR RWD for FDA Regulated Submission and Clinical Research." The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing...
This federal contract award, valued at $811,126.00, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract was awarded under a Broad Agency Announcement (BAA) solicitation for research and development to support the FDA's regulatory science and innovation mission. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and has an ultimate completion date of December 31,...
This is a $14,955 firm-fixed-price purchase order awarded to SHI International Corp, a minority-owned, woman-owned, Asian-Pacific American-owned small business, by the Food and Drug Administration (FDA). The order was placed against SHI's existing General Services Administration (GSA) Federal Supply Schedule (FSS) contract #47QTCA19D005D. The order is for the delivery of IT products and services, including hardware like servers, laptops, printers, and related equipment, as well as software...
This firm fixed-price delivery order was awarded by the Department of Health and Human Services Food and Drug Administration to Disys Solutions, Inc. (DSI) under the Solutions for Enterprise Wide Procurement V (SEWP V) government-wide acquisition contract (GWAC). The $20,328.00 award is for a new 5-year maintenance contract for five Fujitsu scanners, with a completion date of September 30, 2025. DSI is a Minority Owned, Subcontinent Asian (Asian-Indian) American Owned business that has...

This $91,390 firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Digim Solution LLC, a minority-owned, for-profit, Asian-Pacific American business located in Woburn, Massachusetts. The contract is for the provision of image processing, modeling, and simulation software to support the FDA's regulatory and scientific evaluation activities. This award is part of a larger $5,000,500 indefinite delivery vehicle (IDV) contract with the FDA that Digim Solution LLC was previously awarded, which is focused on 3D microscopy, artificial intelligence-based quantification, and modeling to support the non-clinical evaluation and regulatory activities for complex drug products. The contract does not have a set-aside designation.

Generated 8/6/25, 9:47 AM